Insider: Bensen Daniel Chief Discovery Officer - Tyra Biosciences, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 146,981 | 0 | 146,981 |
| Value | $5,626,432.68 | $0.00 | $5,626,432.68 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/12/2026 | DDS | 5,872 | Direct | COM | $33.37 | $195,928.68 | 146,981 |
| 02/12/2026 | DDS | 2,128 | Direct | COM | $31.50 | $67,035.83 | 152,853 |
| 01/12/2026 | DDS | 6,983 | Direct | COM | $28.44 | $198,610.49 | 155,998 |
| 01/12/2026 | DDS | 1,017 | Direct | COM | $29.08 | $29,575.17 | 154,981 |
| 12/12/2025 | DDS | 8,000 | Direct | COM | $22.64 | $181,159.20 | 162,981 |
| 11/19/2025 | DDS | 49,956 | Direct | COM | $16.32 | $815,296.91 | 170,981 |
| 11/18/2025 | DDS | 75,633 | Direct | COM | $16.07 | $1,215,626.52 | 220,937 |
| 11/17/2025 | DDS | 18,572 | Direct | COM | $16.11 | $299,191.21 | 298,070 |
| 11/17/2025 | DDS | 1,500 | Direct | COM | $17.07 | $25,606.95 | 296,570 |
| 11/14/2025 | DDS | 110,228 | Direct | COM | $16.02 | $1,765,488.81 | 316,642 |
| 11/13/2025 | DDS | 1,111 | Direct | COM | $16.00 | $17,780.00 | 426,870 |
| 06/10/2024 | DDS | 3,502 | Direct | COM | $20.00 | $70,044.90 | 427,981 |
| 06/07/2024 | DDS | 200 | Direct | COM | $20.00 | $4,000.00 | 431,483 |
| 03/11/2024 | DDS | 200 | Direct | COM | $20.00 | $4,000.00 | 431,683 |
| 03/07/2024 | DDS | 68 | Direct | COM | $20.00 | $1,360.00 | 431,883 |
| 03/06/2024 | DDS | 1,733 | Direct | COM | $20.09 | $34,819.44 | 431,951 |
| 03/05/2024 | DDS | 1,189 | Direct | COM | $20.02 | $23,802.47 | 433,684 |
| 03/04/2024 | DDS | 5,063 | Direct | COM | $20.08 | $101,653.90 | 434,873 |
| 03/01/2024 | DDS | 2,900 | Direct | COM | $20.04 | $58,111.94 | 439,936 |
| 02/29/2024 | DDS | 2,050 | Direct | COM | $20.00 | $41,003.28 | 442,836 |
| 02/28/2024 | DDS | 5,849 | Direct | COM | $20.13 | $117,728.67 | 444,886 |
| 02/27/2024 | DDS | 745 | Direct | COM | $20.00 | $14,900.00 | 450,735 |
| 02/12/2024 | DDS | 1,501 | Direct | COM | $20.00 | $30,020.00 | 451,480 |
| 02/07/2024 | DDS | 9,587 | Direct | COM | $18.09 | $173,466.22 | 452,981 |
| 02/06/2024 | DDS | 15,413 | Direct | COM | $18.09 | $278,827.34 | 462,568 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research